These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6142448)

  • 21. [Withdrawal of delayed-action neuroleptics in psychotic patients].
    Maillard M; Coutanceau R; Marchina JC
    Ann Med Psychol (Paris); 1979; 137(3-4):351-5. PubMed ID: 40514
    [No Abstract]   [Full Text] [Related]  

  • 22. Impace of depot neuroleptics on psychiatry.
    Corbett L
    Minn Med; 1979 Feb; 62(2):97-100. PubMed ID: 34788
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication.
    Nesvåg R; Hendset M; Refsum H; Tanum L
    Acta Psychiatr Scand; 2006 Jul; 114(1):21-6. PubMed ID: 16774657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospitalization Risk Before and After Discontinuation of Long-Acting Injectable Antipsychotics.
    Yoshimura B; Kishi Y
    J Clin Psychopharmacol; 2016 Feb; 36(1):86-7. PubMed ID: 26637068
    [No Abstract]   [Full Text] [Related]  

  • 25. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
    Auch W
    Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
    [No Abstract]   [Full Text] [Related]  

  • 26. Three long-acting neuroleptic drugs. Comparative study.
    de Francisco CP
    Int J Neurol; 1975; 10(1-4):41-5. PubMed ID: 1181318
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences with depot form flupenthixol].
    Bruck J; Guss H
    Wien Med Wochenschr; 1971 Feb; 121(7):110-2. PubMed ID: 5545657
    [No Abstract]   [Full Text] [Related]  

  • 28. Depot antipsychotic drugs and prevention of psychotic relapse.
    Barnes TR
    Clin Neuropharmacol; 1991; 14 Suppl 2():S1-6. PubMed ID: 1684307
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of depot antipsychotic prescribing in southern Adelaide.
    Herriot P; Kheirani K
    Australas Psychiatry; 2005 Sep; 13(3):253-7. PubMed ID: 16174198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between subjective well-being and pharmacological therapy in patients with psychotic disorders].
    Antonini V; Corradi A; Buizza C; Vittorielli M; Pioli R; Rossi G
    Recenti Prog Med; 2004 Dec; 95(12):581-4. PubMed ID: 15666490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switching antipsychotic medications: a 2-year chart-review study exploring patient characteristics and psychiatric service use of schizophrenia patients.
    Schneider AL; Mosier KE; Tempier RP
    J Clin Psychiatry; 2009 Jun; 70(6):937-9. PubMed ID: 19573492
    [No Abstract]   [Full Text] [Related]  

  • 33. [7 years of experience with delayed action neuroleptics].
    Noguera Hosta R; Rendueles de Olmedo G
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(3):293-8. PubMed ID: 31066
    [No Abstract]   [Full Text] [Related]  

  • 34. Depot antipsychotics. Patient characteristics and prescribing pattern.
    Al-Sughayir MA
    Saudi Med J; 2000 Dec; 21(12):1178-81. PubMed ID: 11360095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
    Gutwinski S; Müller P; Koller M
    Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is depot medication safe in the setting of myopathy?
    Price JR; Bastiampillai T; Dhillon RS
    Aust N Z J Psychiatry; 2009 Aug; 43(8):781-3. PubMed ID: 19629801
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
    Polácek J
    Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
    [No Abstract]   [Full Text] [Related]  

  • 38. Antipsychotic prescribing patterns in the Texas prison system.
    Baillargeon J; Contreras SA
    J Am Acad Psychiatry Law; 2001; 29(1):48-53. PubMed ID: 11302386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial of teaching practice nurses to carry out structured assessments of patients receiving depot antipsychotic injections.
    Burns T; Millar E; Garland C; Kendrick T; Chisholm B; Ross F
    Br J Gen Pract; 1998 Dec; 48(437):1845-8. PubMed ID: 10198505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.